THYMOMA
Clinical trials for THYMOMA explained in plain language.
Never miss a new study
Get alerted when new THYMOMA trials appear
Sign up with your email to follow new studies for THYMOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy offers hope for rare thymus cancers after standard treatment fails
Disease control Recruiting nowThis study tests a combination of two drugs, tislelizumab and anlotinib, as a second treatment option for people with thymoma or thymic carcinoma whose cancer worsened after initial chemotherapy. The trial will enroll 20 participants and measure how many patients see their tumors…
Matched conditions: THYMOMA
Phase: PHASE2 • Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Disease control
Last updated May 26, 2026 04:02 UTC
-
Could extra radiation after thymoma surgery boost survival?
Disease control Recruiting nowThis study looks at whether giving radiation therapy after completely removing a thymoma (a rare chest tumor) can help people with stage II or III disease live longer without the cancer coming back. About 238 adults aged 18-75 who had surgery within the last 3 months will be rand…
Matched conditions: THYMOMA
Phase: NA • Sponsor: Fudan University • Aim: Disease control
Last updated May 26, 2026 03:57 UTC
-
Promising drug tested for rare thymus cancers
Disease control Recruiting nowThis study tests a drug called sacituzumab govitecan in adults with advanced thymoma or thymic carcinoma that has worsened after at least one prior treatment. The main goal is to see how many patients' tumors shrink or disappear. Participants receive the drug intravenously weekly…
Matched conditions: THYMOMA
Phase: PHASE2 • Sponsor: Georgetown University • Aim: Disease control
Last updated May 20, 2026 11:54 UTC
-
Tissue bank study aims to unlock secrets of rare cancer
Knowledge-focused Recruiting nowThis study collects blood, urine, tumor samples, and health information from up to 1,000 people with malignant mesothelioma and other cancers that express mesothelin. The goal is to build a tissue bank for future research, not to test a new treatment. Participants must be at leas…
Matched conditions: THYMOMA
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated May 26, 2026 03:59 UTC